CN103059083A - 一种曲克芦丁结晶母液的纯化工艺 - Google Patents
一种曲克芦丁结晶母液的纯化工艺 Download PDFInfo
- Publication number
- CN103059083A CN103059083A CN2012105905468A CN201210590546A CN103059083A CN 103059083 A CN103059083 A CN 103059083A CN 2012105905468 A CN2012105905468 A CN 2012105905468A CN 201210590546 A CN201210590546 A CN 201210590546A CN 103059083 A CN103059083 A CN 103059083A
- Authority
- CN
- China
- Prior art keywords
- troxerutin
- solution
- resin
- flocculating agent
- crystalline mother
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960003232 troxerutin Drugs 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims abstract description 23
- 239000012452 mother liquor Substances 0.000 title claims abstract description 7
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 title abstract description 9
- 238000002425 crystallisation Methods 0.000 title abstract description 4
- 230000008025 crystallization Effects 0.000 title abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000011347 resin Substances 0.000 claims abstract description 33
- 229920005989 resin Polymers 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000008394 flocculating agent Substances 0.000 claims abstract description 26
- 239000012535 impurity Substances 0.000 claims abstract description 8
- 230000008929 regeneration Effects 0.000 claims abstract description 7
- 238000011069 regeneration method Methods 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 5
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 4
- 230000001172 regenerating effect Effects 0.000 claims abstract description 3
- IYVFNTXFRYQLRP-VVSTWUKXSA-N 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4h-chromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(OCCO)C=C3OC=2C=2C=C(OCCO)C(OCCO)=CC=2)=O)O1 IYVFNTXFRYQLRP-VVSTWUKXSA-N 0.000 claims description 40
- 239000010413 mother solution Substances 0.000 claims description 22
- 238000003756 stirring Methods 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 14
- 239000008213 purified water Substances 0.000 claims description 14
- 238000005189 flocculation Methods 0.000 claims description 13
- 230000016615 flocculation Effects 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 238000010828 elution Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- 238000011284 combination treatment Methods 0.000 claims description 2
- 239000005446 dissolved organic matter Substances 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 239000000088 plastic resin Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- 239000012065 filter cake Substances 0.000 claims 2
- 239000003463 adsorbent Substances 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 235000011114 ammonium hydroxide Nutrition 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000009977 dual effect Effects 0.000 claims 1
- 238000007701 flash-distillation Methods 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
- 239000006071 cream Substances 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000018109 developmental process Effects 0.000 abstract 1
- 239000003480 eluent Substances 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 239000002699 waste material Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 4
- -1 hydroxyethyl rutin Chemical compound 0.000 description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 4
- 235000005493 rutin Nutrition 0.000 description 4
- 229960004555 rutoside Drugs 0.000 description 4
- 230000003311 flocculating effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000000274 adsorptive effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000008728 vascular permeability Effects 0.000 description 2
- IOYNGCZNYGEZRO-UHFFFAOYSA-N 3-ethyl-n,n,2-trimethyl-1h-indol-5-amine Chemical compound C1=C(N(C)C)C=C2C(CC)=C(C)NC2=C1 IOYNGCZNYGEZRO-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 208000003569 Central serous chorioretinopathy Diseases 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 108010025252 Kassinin Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210590546.8A CN103059083B (zh) | 2012-12-31 | 2012-12-31 | 一种曲克芦丁结晶母液的纯化工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210590546.8A CN103059083B (zh) | 2012-12-31 | 2012-12-31 | 一种曲克芦丁结晶母液的纯化工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103059083A true CN103059083A (zh) | 2013-04-24 |
CN103059083B CN103059083B (zh) | 2016-06-08 |
Family
ID=48102011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210590546.8A Expired - Fee Related CN103059083B (zh) | 2012-12-31 | 2012-12-31 | 一种曲克芦丁结晶母液的纯化工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103059083B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106892950A (zh) * | 2017-03-02 | 2017-06-27 | 河南师范大学 | 一种高含量曲克芦丁的制备方法 |
CN106905394A (zh) * | 2017-03-02 | 2017-06-30 | 河南师范大学 | 一种高效回收利用曲克芦丁结晶母液的方法 |
CN107501366A (zh) * | 2017-08-16 | 2017-12-22 | 西安医学院 | 一种从曲克芦丁废液粉中纯化曲克芦丁的方法 |
CN111333602A (zh) * | 2020-04-16 | 2020-06-26 | 四川迪菲特药业有限公司 | 一种曲克芦丁生产废弃母液的回收转化工艺 |
CN115611955A (zh) * | 2022-12-02 | 2023-01-17 | 江西绿天食品有限公司 | 一种曲克芦丁中环氧乙烷的去除工艺 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1032658A (zh) * | 1987-10-19 | 1989-05-03 | 烟台人民制药厂 | 芦丁羟乙基衍生物的精制方法 |
CN1554353A (zh) * | 2003-12-26 | 2004-12-15 | 四川协力制药有限公司 | 一种高含量的曲克芦丁药物及其制备方法 |
-
2012
- 2012-12-31 CN CN201210590546.8A patent/CN103059083B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1032658A (zh) * | 1987-10-19 | 1989-05-03 | 烟台人民制药厂 | 芦丁羟乙基衍生物的精制方法 |
CN1554353A (zh) * | 2003-12-26 | 2004-12-15 | 四川协力制药有限公司 | 一种高含量的曲克芦丁药物及其制备方法 |
Non-Patent Citations (1)
Title |
---|
张雪荣: "《药物分离与纯化技术》", 31 January 2011, 化学工业出版社 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106892950A (zh) * | 2017-03-02 | 2017-06-27 | 河南师范大学 | 一种高含量曲克芦丁的制备方法 |
CN106905394A (zh) * | 2017-03-02 | 2017-06-30 | 河南师范大学 | 一种高效回收利用曲克芦丁结晶母液的方法 |
CN106892950B (zh) * | 2017-03-02 | 2020-03-17 | 河南师范大学 | 一种高含量曲克芦丁的制备方法 |
CN107501366A (zh) * | 2017-08-16 | 2017-12-22 | 西安医学院 | 一种从曲克芦丁废液粉中纯化曲克芦丁的方法 |
CN107501366B (zh) * | 2017-08-16 | 2020-08-25 | 西安医学院 | 一种从曲克芦丁废液粉中纯化曲克芦丁的方法 |
CN111333602A (zh) * | 2020-04-16 | 2020-06-26 | 四川迪菲特药业有限公司 | 一种曲克芦丁生产废弃母液的回收转化工艺 |
CN111333602B (zh) * | 2020-04-16 | 2022-12-16 | 四川协力制药股份有限公司 | 一种曲克芦丁生产废弃母液的回收转化工艺 |
CN115611955A (zh) * | 2022-12-02 | 2023-01-17 | 江西绿天食品有限公司 | 一种曲克芦丁中环氧乙烷的去除工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN103059083B (zh) | 2016-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103059083A (zh) | 一种曲克芦丁结晶母液的纯化工艺 | |
CN104707579B (zh) | 一种用于重金属及染料吸附的超支化聚醚胺接枝go吸附剂的制备及应用 | |
CN103693711A (zh) | 利用弱酸离子交换纤维处理含镍/含铜电镀废水的方法 | |
CN106831804B (zh) | 离子交换和硅胶柱层析法分离制备汉防己甲、乙素的方法 | |
CN101033231B (zh) | 一种高纯度医用黄腐酸的制备方法 | |
CN105110544A (zh) | 一种大孔树脂处理稀碱废水的方法 | |
CN104086017A (zh) | 一种h酸离析废水的处理方法 | |
CN104046805A (zh) | 一种风化壳淋积型稀土矿浸出液中稀土离子回收的方法 | |
CN102730721A (zh) | 聚苯硫醚生产中副产物氯化钠的回收方法 | |
CN106995398A (zh) | L‑脯氨酸提取新工艺 | |
CN101973995A (zh) | 一种叶酸生产废水循环利用的方法 | |
CN102303941B (zh) | 一种氧化铝厂赤泥的深度脱碱方法 | |
CN103723736B (zh) | 一种白炭黑生产工艺中资源回收的方法 | |
CN102153635A (zh) | 从太湖蓝藻中提取微囊藻毒素-lr的方法 | |
CN105771920A (zh) | 一种谷氨酸钠修饰的碱木质素基吸附材料的制备方法及其在去除废水染料中的应用 | |
CN105688742B (zh) | 一种n‑辛烷基山竹果皮多酚表面活性剂的制备方法 | |
CN103193800B (zh) | 一种从头孢克洛酶促反应液中分离纯化各组分的方法 | |
CN108129290B (zh) | 一种去除乳酸中硫酸根的方法 | |
CN110872166A (zh) | 强力霉素脱水废水中对甲苯磺酸的回收方法 | |
CN107128955B (zh) | 一种从温泉水中提取碳酸锂的方法 | |
CN112707807B (zh) | 4,5-二氟邻苯二甲酸的制备方法 | |
CN108275712A (zh) | 一种炉甘石粉的合成方法 | |
CN211546375U (zh) | 2-巯基苯并噻唑粗品的提纯系统 | |
CN100361724C (zh) | 一种n-乙酰乙酰替苯胺生产废水的处理方法 | |
CN105061196A (zh) | 一种从柠檬酸钾末道母液中提纯柠檬酸钾的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Huxian 710309 Shaanxi province Xi'an city qinduzhen Street Applicant after: Li Yushan Address before: 710075 Shaanxi Province, Xi'an City High Road No. 25 building 16D enjoye Applicant before: Li Yushan |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180516 Address after: 710075 room 11604, Ruixin mansion 25, Gaoxin Road, Xi'an, Shaanxi. Patentee after: Shaanxi Huifeng Pharmaceutical Co., Ltd. Address before: 710309 Xi'an City, Shaanxi Province, Huxian Qin crossing town street Patentee before: Li Yushan |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Li Yushan Document name: Notification of Passing Examination on Formalities |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160608 Termination date: 20181231 |